• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超越增殖:KLF5通过直接调控VEGFA转录促进膀胱癌血管生成。

Beyond proliferation: KLF5 promotes angiogenesis of bladder cancer through directly regulating VEGFA transcription.

作者信息

Gao Yang, Wu Kaijie, Chen Yule, Zhou Jiancheng, Du Chong, Shi Qi, Xu Shan, Jia Jing, Tang Xiaoshuang, Li Feng, Hui Ke, He Dalin, Guo Peng

机构信息

Department of Urology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.

Oncology Research Lab, Key Laboratory of Environment and Genes Related to Diseases, Ministry of Education, Xi'an, Shaanxi, China.

出版信息

Oncotarget. 2015 Dec 22;6(41):43791-805. doi: 10.18632/oncotarget.6101.

DOI:10.18632/oncotarget.6101
PMID:26544730
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4791267/
Abstract

Abundant evidence has demonstrated critical roles of KLF5 in regulating cell proliferation in various cancers, however, its additional roles in other aspects of cancer development remain to be further clarified. In this study, we found that KLF5 was essential for cancer cell-endothelial cell interaction in vitro and tumor angiogenesis in nude mice based on lentivirus-mediated KLF5 knockdown bladder cancer cell models. Moreover, KLF5 insufficiency abolished the ability of bladder cancer cells to induce neovascularization in rabbit cornea. Mechanistically, the pro-angiogenic factor VEGFA was identified as a direct downstream target of KLF5, which bound to GC-boxes and CACCC elements of VEGFA promoter and regulated its transcriptional activity. In addition, there was a positive correlation between KLF5 and VEGFA expression in human bladder cancer tissues by immunohistochemistry assay and statistical analysis from TCGA and GEO data. Furthermore, we found that two pivotal pathways in bladder cancer, RTKs/RAS/MAPK and PI3K/Akt, might convey their oncogenic signaling through KLF5-VEGFA axis. Taken together, our results indicate that KLF5 promotes angiogenesis of bladder cancer through directly regulating VEGFA transcription and suggest that KLF5 could be a novel therapeutic target for angiogenesis inhibition in bladder cancer.

摘要

大量证据表明KLF5在调控多种癌症的细胞增殖中发挥关键作用,然而,其在癌症发展其他方面的额外作用仍有待进一步阐明。在本研究中,基于慢病毒介导的KLF5敲低膀胱癌细胞模型,我们发现KLF5在体外对于癌细胞-内皮细胞相互作用以及裸鼠肿瘤血管生成至关重要。此外,KLF5功能不足消除了膀胱癌细胞在兔角膜中诱导新血管形成的能力。从机制上讲,促血管生成因子VEGFA被确定为KLF5的直接下游靶点,KLF5与VEGFA启动子的GC盒和CACCC元件结合并调节其转录活性。此外,通过免疫组织化学分析以及来自TCGA和GEO数据的统计分析,发现人膀胱癌组织中KLF5与VEGFA表达呈正相关。此外,我们发现膀胱癌中的两条关键信号通路RTKs/RAS/MAPK和PI3K/Akt可能通过KLF5-VEGFA轴传递其致癌信号。综上所述,我们的结果表明KLF5通过直接调节VEGFA转录促进膀胱癌血管生成,并提示KLF5可能是膀胱癌血管生成抑制的一个新的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc1f/4791267/45ac85c0b3fc/oncotarget-06-43791-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc1f/4791267/ed9ad6b1db9a/oncotarget-06-43791-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc1f/4791267/45ac85c0b3fc/oncotarget-06-43791-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc1f/4791267/ed9ad6b1db9a/oncotarget-06-43791-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc1f/4791267/45ac85c0b3fc/oncotarget-06-43791-g006.jpg

相似文献

1
Beyond proliferation: KLF5 promotes angiogenesis of bladder cancer through directly regulating VEGFA transcription.超越增殖:KLF5通过直接调控VEGFA转录促进膀胱癌血管生成。
Oncotarget. 2015 Dec 22;6(41):43791-805. doi: 10.18632/oncotarget.6101.
2
KLF5 promotes cell proliferation and tumorigenesis through gene regulation and the TSU-Pr1 human bladder cancer cell line.KLF5通过基因调控和TSU-Pr1人膀胱癌细胞系促进细胞增殖和肿瘤发生。
Int J Cancer. 2006 Mar 15;118(6):1346-55. doi: 10.1002/ijc.21533.
3
Adenoviral mediated interferon-alpha 2b gene therapy suppresses the pro-angiogenic effect of vascular endothelial growth factor in superficial bladder cancer.腺病毒介导的α-干扰素2b基因治疗抑制浅表性膀胱癌中血管内皮生长因子的促血管生成作用。
J Urol. 2007 May;177(5):1900-6. doi: 10.1016/j.juro.2007.01.003.
4
KLF5 promotes cell migration by up-regulating FYN in bladder cancer cells.KLF5通过上调膀胱癌细胞中的FYN来促进细胞迁移。
FEBS Lett. 2016 Feb;590(3):408-18. doi: 10.1002/1873-3468.12069. Epub 2016 Feb 1.
5
KLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1α accumulation.KLF5通过减弱AKT激活及随后的HIF1α积累来抑制PTEN缺陷型前列腺癌中的血管生成。
Mol Cancer. 2015 Apr 21;14:91. doi: 10.1186/s12943-015-0365-6.
6
Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.Krüppel样因子5部分通过上调成纤维细胞生长因子结合蛋白1的转录来促进乳腺细胞增殖。
Oncogene. 2009 Oct 22;28(42):3702-13. doi: 10.1038/onc.2009.235. Epub 2009 Aug 10.
7
Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway.环状RNA MYLK作为一种竞争性内源性RNA,通过调节VEGFA/VEGFR2信号通路促进膀胱癌进展。
Cancer Lett. 2017 Sep 10;403:305-317. doi: 10.1016/j.canlet.2017.06.027. Epub 2017 Jul 4.
8
Krüppel-like factor 8 regulates VEGFA expression and angiogenesis in hepatocellular carcinoma.Krüppel 样因子 8 调节肝细胞癌中的 VEGFA 表达和血管生成。
Sci Rep. 2018 Nov 27;8(1):17415. doi: 10.1038/s41598-018-35786-6.
9
CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.CCL5/CCR5 轴诱导人骨肉瘤微环境中血管内皮生长因子介导的肿瘤血管生成。
Carcinogenesis. 2015 Jan;36(1):104-14. doi: 10.1093/carcin/bgu218. Epub 2014 Oct 20.
10
CINP is a novel cofactor of KLF5 required for its role in the promotion of cell proliferation, survival and tumor growth.CINP 是 KLF5 的一种新型辅助因子,对于 KLF5 在促进细胞增殖、存活和肿瘤生长中的作用至关重要。
Int J Cancer. 2019 Feb 1;144(3):582-594. doi: 10.1002/ijc.31908. Epub 2018 Oct 26.

引用本文的文献

1
Loss of Zonula Occludens-1 (ZO-1) Enhances Angiogenic Signaling in Ovarian Cancer Cells.闭合蛋白1(ZO-1)缺失增强卵巢癌细胞中的血管生成信号。
Int J Mol Sci. 2025 Aug 29;26(17):8389. doi: 10.3390/ijms26178389.
2
linc-ADAIN, a human adipose lincRNA, regulates adipogenesis by modulating KLF5 and IL-8 mRNA stability.linc-ADAIN,一种人类脂肪 lincRNA,通过调节 KLF5 和 IL-8 mRNA 的稳定性来调节脂肪生成。
Cell Rep. 2024 May 28;43(5):114240. doi: 10.1016/j.celrep.2024.114240. Epub 2024 May 14.
3
The urothelial gene regulatory network: understanding biology to improve bladder cancer management.

本文引用的文献

1
KLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1α accumulation.KLF5通过减弱AKT激活及随后的HIF1α积累来抑制PTEN缺陷型前列腺癌中的血管生成。
Mol Cancer. 2015 Apr 21;14:91. doi: 10.1186/s12943-015-0365-6.
2
FoxM1 promotes breast tumorigenesis by activating PDGF-A and forming a positive feedback loop with the PDGF/AKT signaling pathway.FoxM1通过激活血小板衍生生长因子A(PDGF-A)并与PDGF/AKT信号通路形成正反馈回路来促进乳腺肿瘤发生。
Oncotarget. 2015 May 10;6(13):11281-94. doi: 10.18632/oncotarget.3596.
3
Cancer statistics, 2015.
尿路上皮基因调控网络:通过理解生物学原理改善膀胱癌治疗
Oncogene. 2024 Jan;43(1):1-21. doi: 10.1038/s41388-023-02876-3. Epub 2023 Nov 23.
4
An Overview of Angiogenesis in Bladder Cancer.膀胱癌中的血管生成概述。
Curr Oncol Rep. 2023 Jul;25(7):709-728. doi: 10.1007/s11912-023-01421-5. Epub 2023 Apr 13.
5
Krüppel-like factors in tumors: Key regulators and therapeutic avenues.肿瘤中的Krüppel样因子:关键调节因子与治疗途径
Front Oncol. 2023 Jan 25;13:1080720. doi: 10.3389/fonc.2023.1080720. eCollection 2023.
6
Deciphering Pro-angiogenic Transcription Factor Profiles in Hypoxic Human Endothelial Cells by Combined Bioinformatics and Modeling.通过联合生物信息学和建模解析缺氧人内皮细胞中的促血管生成转录因子谱
Front Cardiovasc Med. 2022 Jun 17;9:877450. doi: 10.3389/fcvm.2022.877450. eCollection 2022.
7
Epigenetic reader BRD4 supports mycobacterial pathogenesis by co-modulating host lipophagy and angiogenesis.表观遗传读码器 BRD4 通过共同调节宿主脂噬作用和血管生成来支持分枝杆菌发病机制。
Autophagy. 2022 Feb;18(2):391-408. doi: 10.1080/15548627.2021.1936355. Epub 2021 Jun 28.
8
Single-cell transcriptomics reveals the landscape of intra-tumoral heterogeneity and transcriptional activities of ECs in CC.单细胞转录组学揭示了宫颈癌中肿瘤内异质性景观以及内皮细胞的转录活性。
Mol Ther Nucleic Acids. 2021 Apr 2;24:682-694. doi: 10.1016/j.omtn.2021.03.017. eCollection 2021 Jun 4.
9
The roles and regulation of the KLF5 transcription factor in cancers.KLF5 转录因子在癌症中的作用和调控。
Cancer Sci. 2021 Jun;112(6):2097-2117. doi: 10.1111/cas.14910. Epub 2021 May 3.
10
Current knowledge of Krüppel-like factor 5 and vascular remodeling: providing insights for therapeutic strategies.Krüppel 样因子 5 与血管重构的研究现状:为治疗策略提供新视角。
J Mol Cell Biol. 2021 May 7;13(2):79-90. doi: 10.1093/jmcb/mjaa080.
癌症统计数据,2015 年。
CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29. doi: 10.3322/caac.21254. Epub 2015 Jan 5.
4
Curcumin promotes KLF5 proteasome degradation through downregulating YAP/TAZ in bladder cancer cells.姜黄素通过下调膀胱癌细胞中的YAP/TAZ促进KLF5蛋白酶体降解。
Int J Mol Sci. 2014 Aug 28;15(9):15173-87. doi: 10.3390/ijms150915173.
5
miR-145 inhibits invasion of bladder cancer cells by targeting PAK1.微小RNA-145通过靶向p21蛋白(Cdc42/Rac)激活激酶1抑制膀胱癌细胞的侵袭。
Urol Oncol. 2014 Aug;32(6):846-54. doi: 10.1016/j.urolonc.2014.01.003. Epub 2014 Jun 20.
6
Interruption of KLF5 acetylation converts its function from tumor suppressor to tumor promoter in prostate cancer cells.在前列腺癌细胞中,KLF5乙酰化作用的中断将其功能从肿瘤抑制因子转变为肿瘤促进因子。
Int J Cancer. 2015 Feb 1;136(3):536-46. doi: 10.1002/ijc.29028. Epub 2014 Jun 28.
7
Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.鉴定具有不同一线化疗敏感性的浸润性膀胱癌的基底和腔面亚型。
Cancer Cell. 2014 Feb 10;25(2):152-65. doi: 10.1016/j.ccr.2014.01.009.
8
Comprehensive molecular characterization of urothelial bladder carcinoma.尿路上皮膀胱癌的综合分子特征分析
Nature. 2014 Mar 20;507(7492):315-22. doi: 10.1038/nature12965. Epub 2014 Jan 29.
9
Whole-genome sequencing identifies genomic heterogeneity at a nucleotide and chromosomal level in bladder cancer.全基因组测序在膀胱癌中鉴定出核苷酸和染色体水平的基因组异质性。
Proc Natl Acad Sci U S A. 2014 Feb 11;111(6):E672-81. doi: 10.1073/pnas.1313580111. Epub 2014 Jan 27.
10
Inducible intestine-specific deletion of Krüppel-like factor 5 is characterized by a regenerative response in adult mouse colon.诱导型肠道特异性 Krüppel 样因子 5 缺失的特征是成年小鼠结肠的再生反应。
Dev Biol. 2014 Mar 15;387(2):191-202. doi: 10.1016/j.ydbio.2014.01.002. Epub 2014 Jan 15.